Consolidated Cash Flow Statement

Consolidated cash flow statement

€ million

 

Note

 

2024

 

2023

Profit after tax

 

 

 

2,786

 

2,834

Depreciation/amortization/impairment losses/reversals of impairment losses

 

 

 

2,134

 

1,880

Changes in inventories

 

 

 

36

 

-89

Changes in trade accounts receivable

 

 

 

79

 

-8

Changes in trade accounts payable/refund liabilities

 

 

 

-178

 

-43

Changes in provisions

 

 

 

62

 

188

Changes in other assets and liabilities

 

 

 

-309

 

-755

Neutralization of gains/losses on disposal of fixed assets and other disposals

 

 

 

-2

 

-150

Other non-cash income and expenses

 

 

 

-22

 

-72

Operating Cash Flow

 

16

 

4,586

 

3,784

 

 

 

 

 

 

 

Payments for investments in intangible assets

 

 

 

-482

 

-216

Proceeds from the disposal of intangible assets

 

 

 

18

 

136

Payments for investments in property, plant and equipment

 

 

 

-1,702

 

-1,807

Proceeds from the disposal of property, plant and equipment

 

 

 

27

 

19

Payments for investments in other assets1

 

 

 

-2,251

 

-3,031

Proceeds from the disposal of other assets1

 

 

 

2,107

 

3,021

Payments for acquisitions less acquired cash and cash equivalents (net)

 

 

 

-774

 

-12

Proceeds from divestments

 

 

 

7

 

Investing Cash Flow

 

23

 

-3,050

 

-1,892

 

 

 

 

 

 

 

Dividend payments to shareholders of Merck KGaA, Darmstadt, Germany

 

 

 

-284

 

-284

Dividend payments to non-controlling interests

 

 

 

-9

 

-12

Profit withdrawal by E. Merck KG, Darmstadt, Germany

 

 

 

-747

 

-868

Proceeds from new borrowings of financial debt from E. Merck KG, Darmstadt, Germany and E. Merck Beteiligungen KG, Darmstadt, Germany

 

 

 

683

 

697

Repayment of financial debt to E. Merck KG, Darmstadt, Germany and E. Merck Beteiligungen KG, Darmstadt, Germany

 

 

 

-453

 

-420

Proceeds from new borrowings of other current and non-current financial debt

 

 

 

2,113

 

519

Repayment of other current and non-current financial debt

 

 

 

-2,290

 

-1,364

Financing Cash Flow

 

41

 

-985

 

-1,732

 

 

 

 

 

 

 

Changes in cash and cash equivalents

 

 

 

551

 

160

Changes in cash and cash equivalents due to currency translation

 

 

 

-16

 

-31

Cash and cash equivalents as of January 1

 

 

 

1,982

 

1,854

Cash and cash equivalents as of December 31
(consolidated balance sheet)

 

35

 

2,517

 

1,982

1

Prior-year figures have been adjusted, see note (2) "Reporting principles".

Share this page: